Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03055364 · ClinicalTrials.gov registry record
Cognitive Function After Treatment of Primary CNS Malignancy
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 129
- Enrollment target
NCT03055364: Completed study, sponsored by Mayo Clinic.
NCT03055364 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 129 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03055364 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 129 participants
- Enrollment target
Study Summary
In this study, the investigators propose to evaluate cognitive function and determine the feasibility of neurocognitive assessment using a select CogState test battery in patients with primary intracranial malignancies receiving photon- or proton-based cranial irradiation with curative intent. The investigators will use the CogState software to quantify changes in verbal learning, memory, and executive function over the initial months and years following radiation treatment. Cognitive changes and temporal patterns of function will be compared to baseline performance for each patient. Data regarding cognitive function, fatigue, quality of life, and standard patient reported outcomes will be collected to characterize the daily impact of treatment. In addition, observed outcomes will be correlated with dosimetry values, radiation dose volumes, and anatomic dose distribution.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2017-06-13 |
| Est. Completion | 2023-11-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03055364
The ClinicalTrials.gov registry entry for NCT03055364 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03055364 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03055364 about?
NCT03055364 is a clinical study titled "Cognitive Function After Treatment of Primary CNS Malignancy". In this study, the investigators propose to evaluate cognitive function and determine the feasibility of neurocognitive assessment using a select CogState test battery in patients with primary intracranial malignancies receiving photon- or proton-based cranial irradiation with curative intent. The i...
What is the current status of trial NCT03055364?
This trial is currently completed. The enrollment target is 129 participants. The study started on 2017-06-13. Estimated completion is 2023-11-02.
Who is sponsoring clinical trial NCT03055364?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.